Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
1.232B
Cash
7.391M
Avg Qtr Burn
-4.424M
Short % of Float
0.01%
Insider Ownership
3.01%
Institutional Own.
4.77%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CM24 Details Pancreatic cancer, Cancer | Phase 2 Data readout | |
NT219 [IRS1/2 and STAT3 inhibitor] Details Head and neck squamous cell carcinoma, Cancer | Phase 2 Update |